Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Reshape Lifesciences Inc. is managing 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. All 3 of these actions are located within a single distinct art unit, reflecting a narrow and consistent technical focus for the company's current applications. The company is working with 3 distinct examiners, meaning each pending action is being reviewed by a different person, which requires managing multiple examination styles.
COLLARD JR, DWANE EDWARD is the busiest examiner, responsible for 1 pending office action. Because the busiest examiner pending count is only a portion of the 3 total pending actions, the company's prosecution workload is spread across different examiners within the same art unit. This requires the company to maintain a consistent technical strategy in the Medical Devices & Mechanical Engineering sector while addressing the unique preferences of each examiner. The lack of examiner concentration suggests that the company's success is distributed across multiple points of review.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COLLARD JR, DWANE EDWARD | 1 | 0.0% | +0.0% |
| TEHRANI, DANIEL | 1 | 59.7% | +42.9% |
| SEVERSON, RYAN J | 1 | 82.9% | +13.5% |
| SCHMITT, BENJAMIN ALLYN | 1 | 8.3% | +40.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18818056 | INTRAGASTRIC DEVICE | SEVERSON, RYAN J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19066714 | SIMULTANEOUS MULTI-SITE VAGUS NERVE NEUROMODULATION FOR IMPROVED GLYCEMIC CONTROL SYSTEM AND METHODS | COLLARD JR, DWANE EDWARD | — |
| 18877731 | NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION | TEHRANI, DANIEL | — |
| 17604309 | METHODS AND SYSTEMS FOR NEURAL REGULATION | SCHMITT, BENJAMIN ALLYN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18877731 | NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION | TEHRANI, DANIEL | — |
| 18818056 | INTRAGASTRIC DEVICE | SEVERSON, RYAN J | — |
| 17604309 | METHODS AND SYSTEMS FOR NEURAL REGULATION | SCHMITT, BENJAMIN ALLYN | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| 3796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19066714 | SIMULTANEOUS MULTI-SITE VAGUS NERVE NEUROMODULATION FOR IMPROVED GLYCEMIC CONTROL SYSTEM AND METHODS | COLLARD JR, DWANE EDWARD | — | §102§103§112 | Non-Final OA | — | Pending | Feb 28, 2025 |
| 18877731 | NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION | TEHRANI, DANIEL | — | §102§103 | Final Rejection | — | Pending | Dec 20, 2024 |
| 18818056 | INTRAGASTRIC DEVICE | SEVERSON, RYAN J | 3771 | §112Other | Non-Final OA | — | Pending | Aug 28, 2024 |
| 17604309 | METHODS AND SYSTEMS FOR NEURAL REGULATION | SCHMITT, BENJAMIN ALLYN | 3796 | §103 | Final Rejection | — | Pending | Oct 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial